TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.

Stephen J Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.